Resveratrol, sirtuins, and viruses (Q38610855)

4 September 2017

Resveratrol, sirtuins, and viruses (English)

1 reference

4 September 2017

Tao Yang

1

1 reference

4 September 2017

Shugang Li

2

1 reference

4 September 2017

Xuming Zhang

3

1 reference

4 September 2017

Xiaowu Pang

4

1 reference

4 September 2017

Qinlu Lin

5

1 reference

4 September 2017

Jianzhong Cao

6

1 reference

4 September 2017

19 October 2015

1 reference

Reviews in Medical Virology

4 September 2017

1 reference

4 September 2017

25

1 reference

4 September 2017

6

1 reference

4 September 2017

431-445

1 reference

Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?

4 September 2017

1 reference

Resveratrol: from grapevines to mammalian biology

21 January 2018

1 reference

Antiviral activity of resveratrol

21 January 2018

1 reference

Resveratrol: a molecule whose time has come? And gone?

21 January 2018

1 reference

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia

21 January 2018

1 reference

Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2

21 January 2018

1 reference

Resveratrol is a class IA phosphoinositide 3-kinase inhibitor

21 January 2018

1 reference

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

Resveratrol stimulates AMP kinase activity in neurons

21 January 2018

1 reference

Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway

21 January 2018

1 reference

Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism.

21 January 2018

1 reference

Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation

21 January 2018

1 reference

The molecular targets of resveratrol

21 January 2018

1 reference

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

21 January 2018

1 reference

Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins

21 January 2018

1 reference

The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms

21 January 2018

1 reference

Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans

21 January 2018

1 reference

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

21 January 2018

1 reference

Sir2 mediates longevity in the fly through a pathway related to calorie restriction

21 January 2018

1 reference

Seven sirtuins for seven deadly diseases of aging

21 January 2018

1 reference

Porcine sirtuin 1 gene clone, expression pattern, and regulation by resveratrol

21 January 2018

1 reference

Substrate-specific activation of sirtuins by resveratrol

21 January 2018

1 reference

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

21 January 2018

1 reference

Resveratrol inhibition of herpes simplex virus replication

21 January 2018

1 reference

Nutraceutical activators of AMPK/Sirt1 axis inhibit viral production and protect neurons from neurodegenerative events triggered during HSV-1 infection.

21 January 2018

1 reference

Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice

21 January 2018

1 reference

Effect of resveratrol on herpes simplex virus vaginal infection in the mouse

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines

21 January 2018

1 reference

Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required

21 January 2018

1 reference

Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis

21 January 2018

1 reference

Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle.

21 January 2018

1 reference

Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program

21 January 2018

1 reference

Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1

21 January 2018

1 reference

3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling

21 January 2018

1 reference

Resveratrol inhibition of varicella-zoster virus replication in vitro

21 January 2018

1 reference

Inhibitory effect of resveratrol against duck enteritis virus in vitro

21 January 2018

1 reference

Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol

21 January 2018

1 reference

Targeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1

21 January 2018

1 reference

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

21 January 2018

1 reference

5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors

21 January 2018

1 reference

Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1.

21 January 2018

1 reference

Novel inhibitors of human immunodeficiency virus type 2 infectivity

21 January 2018

1 reference

SIRT1 Suppresses Human T-Cell Leukemia Virus Type 1 Transcription

21 January 2018

1 reference

Inhibition of influenza A virus replication by resveratrol

21 January 2018

1 reference

Interaction of the influenza a virus nucleocapsid protein with the viral RNA polymerase potentiates unprimed viral RNA replication.

21 January 2018

1 reference

Inhibition of influenza virus replication by plant-derived isoquercetin

21 January 2018

1 reference

Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice

21 January 2018

1 reference

Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice

21 January 2018

1 reference

Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells

21 January 2018

1 reference

Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia.

21 January 2018

1 reference

Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use

21 January 2018

1 reference

Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention

21 January 2018

1 reference

Comparative inhibitory activity of the stilbenes resveratrol and oxyresveratrol on African swine fever virus replication.

21 January 2018

1 reference

Portuguese winemaking residues as a potential source of natural anti-adenoviral agents

21 January 2018

1 reference

Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models

21 January 2018

1 reference

Reduction of adenovirus 36-induced obesity and inflammation by mulberry extract

21 January 2018

1 reference

Naturally occurring flavonoids against human norovirus surrogates

21 January 2018

1 reference

Grape seed extract for control of human enteric viruses

21 January 2018

1 reference

An antioxidant resveratrol significantly enhanced replication of hepatitis C virus

21 January 2018

1 reference

The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells

21 January 2018

1 reference

Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency

21 January 2018

1 reference

Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency

21 January 2018

1 reference

Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.

21 January 2018

1 reference

Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture

21 January 2018

1 reference

Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle

21 January 2018

1 reference

Short-chain fatty acids from periodontal pathogens suppress histone deacetylases, EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication

21 January 2018

1 reference

Sirtuins are evolutionarily conserved viral restriction factors

21 January 2018

1 reference

Sirtuin 1 Regulates Dendritic Cell Activation and Autophagy during Respiratory Syncytial Virus-Induced Immune Responses

21 January 2018

1 reference

Hepatitis B virus infection: epidemiology and vaccination

21 January 2018

1 reference

Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1.

21 January 2018

1 reference

Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

21 January 2018

1 reference

Retinoid X receptor RXR alpha binds to and trans-activates the hepatitis B virus enhancer

21 January 2018

1 reference

Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha

21 January 2018

1 reference

PGC-1alpha controls hepatitis B virus through nutritional signals

21 January 2018

1 reference

SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}

21 January 2018

1 reference

GCN5 acetyltransferase inhibits PGC1α-induced hepatitis B virus biosynthesis

21 January 2018

1 reference

The metabolic sensors FXRα, PGC-1α, and SIRT1 cooperatively regulate hepatitis B virus transcription.

21 January 2018

1 reference

Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway

21 January 2018

1 reference

Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein

21 January 2018

1 reference

Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein

21 January 2018

1 reference

Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells

21 January 2018

1 reference

In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions

21 January 2018

1 reference

Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product

21 January 2018

1 reference

HIV-1 tat trans-activation requires the loop sequence within tar.

21 January 2018

1 reference

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

21 January 2018

1 reference

Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation

21 January 2018

1 reference

SIRT1 regulates HIV transcription via Tat deacetylation

21 January 2018

1 reference

SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase

21 January 2018

1 reference

Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation

21 January 2018

1 reference

MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway

21 January 2018

1 reference

21 January 2018

1 reference

Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation

21 January 2018

1 reference

Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells.

21 January 2018

1 reference

SIRT1 sensitizes hepatocellular carcinoma cells expressing hepatitis B virus X protein to oxidative stress-induced apoptosis.

21 January 2018

1 reference

Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model

21 January 2018

1 reference

Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity

21 January 2018

1 reference

Resveratrol Induces Downregulation in Survivin Expression and Apoptosis in HTLV-1-Infected Cell Lines: A Prospective Agent for Adult T Cell Leukemia Chemotherapy

21 January 2018

1 reference

Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells

21 January 2018

1 reference

High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells.

21 January 2018

1 reference

Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells

21 January 2018

1 reference

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets.

21 January 2018

1 reference

Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells

21 January 2018

1 reference

Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells

21 January 2018

1 reference

Potential for combined therapy with 348U87, a ribonucleotide reductase inhibitor, and acyclovir as treatment for acyclovir-resistant herpes simplex virus infection.

21 January 2018

1 reference

Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition

21 January 2018

1 reference

Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production

21 January 2018

1 reference

Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation

21 January 2018

1 reference

The early expressed HIV-1 genes regulate DNMT1 expression

21 January 2018

1 reference

Induction of transcription factor Egr-1 gene expression in astrocytoma cells by Murine coronavirus infection

21 January 2018

1 reference

Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1.

21 January 2018

1 reference

Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1

21 January 2018

1 reference

Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter.

21 January 2018

1 reference

SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1

21 January 2018

1 reference

Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein

21 January 2018

1 reference

Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells

21 January 2018

1 reference

p300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and cell proliferation and survival

21 January 2018

1 reference

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

Up-regulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1.

21 January 2018

1 reference

Autophagy fights disease through cellular self-digestion

21 January 2018

1 reference

Autophagy in the Pathogenesis of Disease

21 January 2018

1 reference

Selective autophagy and viruses

21 January 2018

1 reference

Manipulation or capitulation: virus interactions with autophagy

21 January 2018

1 reference

A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy

21 January 2018

1 reference

SIRT1: regulation of longevity via autophagy

21 January 2018

1 reference

Sirtuins' modulation of autophagy

21 January 2018

1 reference

Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence.

21 January 2018

1 reference

Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity

21 January 2018

1 reference

Sirtuins in mammals: insights into their biological function

21 January 2018

1 reference

Bioenergetic and autophagic control by Sirt3 in response to nutrient deprivation in mouse embryonic fibroblasts

21 January 2018

1 reference

Autophagy, polyphenols and healthy ageing

21 January 2018

1 reference

21 January 2018

1 reference

Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice

21 January 2018

1 reference

AMPK and SIRT1: a long-standing partnership?

21 January 2018

1 reference

Modulation of growth and immunity by dietary supplementation with resveratrol in young chickens receiving conventional vaccinations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.1858

1 reference

4 September 2017

1 reference